Expert Ratings for Elevance Health
Portfolio Pulse from Benzinga Insights
Over the past three months, five analysts have published somewhat bullish opinions on Elevance Health (NYSE:ELV) stock, with an average price target of $570.2, representing an upside from the current price of $466.505. This average price target is a 0.55% decrease from the previous average price target of $573.33.

October 19, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a somewhat bullish outlook on Elevance Health, predicting an upside from the current price.
The bullish outlook from analysts suggests that they believe the stock price will increase in the short term. This is based on their understanding of the company's business and their predictions for its future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100